Drugmaker Insys shares tank after saying opioid lawsuits may force it into bankruptcy

Insys Therapeutics shares tanked Monday morning after the company said it may have to file for bankruptcy because it can't afford legal costs related to a Department of Justice investigation into the company's sales practices of one of its popular opioids.